🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of Tylenol, claiming the firms concealed safety concerns that the medication presented to children's neurological development.

This legal action arrives four weeks after President Donald Trump advocated an unproven link between consuming Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in children.

Paxton is suing Johnson & Johnson, which once produced the drug, the sole analgesic approved for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he claimed they "misled consumers by making money from suffering and pushing pills without regard for the potential hazards."

The company states there is no credible evidence linking Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening millions to increase profits," the attorney general, from the Republican party, declared.

The company commented that it was "very worried by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the health of women and children in America."

On its online platform, the company also stated it had "regularly reviewed the relevant science and there is insufficient valid information that demonstrates a proven link between using paracetamol and autism."

Associations representing physicians and healthcare providers concur.

ACOG has declared acetaminophen - the key substance in acetaminophen - is one of the few options for pregnant women to manage pain and elevated temperature, which can present serious health risks if left untreated.

"In over twenty years of investigation on the consumption of paracetamol in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any period of pregnancy leads to neurodevelopmental disorders in young ones," the group said.

The lawsuit mentions latest statements from the former administration in asserting the drug is reportedly hazardous.

Last month, Trump caused concern from medical authorities when he advised women during pregnancy to "resist strongly" not to consume acetaminophen when sick.

Federal regulators then released a statement that doctors should consider limiting the use of Tylenol, while also stating that "a direct connection" between the drug and autism spectrum disorder in young ones has not been established.

Health Secretary RFK Jr, who manages the Food and Drug Administration, had promised in spring to initiate "extensive scientific investigation" that would establish the source of autism spectrum disorder in a matter of months.

But authorities advised that finding a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complicated interplay of genetic and environmental factors - would be difficult.

Autism is a category of lifelong neurodivergence and disability that impacts how individuals perceive and interact with the environment, and is identified using medical professional evaluations.

In his court filing, the attorney general - a Trump ally who is campaigning for federal office - alleges Kenvue and J&J "intentionally overlooked and attempted to silence the science" around paracetamol and autism spectrum disorder.

The case seeks to make the corporations "destroy any commercial messaging" that states Tylenol is secure for women during pregnancy.

This legal action echoes the concerns of a group of parents of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in 2022.

The court threw out the legal action, declaring investigations from the family's specialists was lacking definitive proof.